News

Key advances on immunotherapy and cellular therapy against cancer and inflammatory diseases

EUROBIOMED presents: key advances and future promises in immunotherapy antibodies and cellular therapies for the treatment of cancers and inflammatory diseases.

Over the last years, immunotherapies have shown very good results notably with the last generation of treatments combining different approaches for the treatment of melanoma and NSCLC. But despite the success and hope, these treatments generate severe adverse reactions, a high proportion of people still do not respond to immunotherapy, and their use in some pathologies are still in the preclinical phase. Lots of efforts are made in order to increase efficacy with new targets, new formats, combination of treatments and with the development of cellular therapies targeting the immune system. All these aspects will be addressed during this one day symposium and we will benefit from the point of view of the French pharmaceutical industry.

Program

9h00

Registration and Coffee

9h30

Welcome words and Eurobiomed presentation

- Xavier Tabary, Sanofi

- Emilie Royere, Pôle Eurobiomed

9h50

The next generation of immunotherapy to increase efficacy (Part I)

- Dr Jean-Jacques Fournié (CRCT - Toulouse)

- Prof. Dr René Hoet (Imcheck Therapeutics - Marseille)

- Dr Julien Faget (IRCM - MabImprove - Montpellier)

10h50

Coffee Break

11h10

The next generation of immunotherapy to increase efficacy (Part II)

- Dr Nicolas Poirier (Ose Immunotherapeutics - Nantes)

- Dr Bruno Ségui (CRCT - Toulouse)

- Dr Hatem A. Azim (Innate Pharma - Marseille)

- Ms. Agnes Menut (MiMabs - Marseille)

12h20Lunch and networking
13h40

Afternoon Lecture

- Prof Christian Chabannon (CTCG, IPC - AP-HM - Marseille)
14h20

New cellular and genetic approaches to treat diseases (Part I)

- Dr Martin Villalba (IRMB - Montpellier)

- Dr Christine Duthoit (Flash Therapeutics - Toulouse)

15h00Coffee Break
15h30

New cellular and genetic approaches to treat diseases (Part II)

- Dr Caroline Courme (Sangamo - Nice)

16h00The pharmaceutical industry's point of view

- Dr. Leda MANNENT (Sanofi)

16h30Conference closing

Chairmen: Prof John De Vos (IRMB - Montpellier) and Prof Pierre Martineau (IRCM - Montpellier)

 

Registrations are now closed.

 

Information: Nicolas REYMOND: nicolas.reymond(at)eurobiomed(dot)org

 

With the support of


                        

 

In partnership with